
S3-E55.3 – NIT Efficacy in Primary Care and Diabetes Clinic Settings
A panel of seven attendees (Jörn Schattenberg, William Alazawi, Naim Alkhouri, Laurent Castera, Kenneth Cusi, Wayne Eskridge and Roger Green) convene to recap the just-concluded 2022 AASLD Liver Meeting. This conversation focuses around the efficacy of NITs for identifying fatty liver disease and progression in primary care and diabetes clinic settings.